Literature DB >> 29462394

Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.

Paula M De Angelis1, Aasa R Schjølberg1, Juliana B Hughes1, Henrik S Huitfeldt2, Solveig Norheim Andersen3, Anne Carine Østvold4.   

Abstract

Background: The colon and rectum are continuously exposed to oxidative stress that generates reactive oxygen species, which are a major cause of DNA double-strand breaks (DSB). Furthermore, chronic inflammatory diseases such as ulcerative colitis (UC) are characterized by an excess of reactive nitrogen species that can also lead to DNA double-strand breakage and genomic instability. We investigated the expression of the nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) protein in UC and sporadic colorectal cancer (CRC) due to its involvement in both DNA double-strand break repair and inflammatory signaling.
Methods: NUCKS1 expression and expression of the DNA double-strand break marker gamma-H2AX (γH2AX) were assessed in formalin-fixed, paraffin-embedded UC and CRC patient biopsies using peroxidase immunohistochemistry. Expression levels for both proteins were evaluated together with previously published expression-level data for hTERT and TP53 proteins in the same material.
Results: Nondysplastic UC lesions had 10-fold lower γH2AX expression and approximately 4-fold higher NUCKS1 expression compared with sporadic CRC, indicating minimal DNA DSB damage and heightened DNA DSB repair in these lesions, respectively. NUCKS1 expression in UC tended to decrease with increasing grades of dysplasia, whereas γH2AX, hTERT, and TP53 expression tended to increase with increasing grades of dysplasia. The highest γH2AX expression was seen in sporadic CRC, indicating considerable DNA DSB damage, whereas the highest NUCKS1 expression and hTERT expression were seen in nondysplastic UC. Conclusions: Overall, our data suggest that NUCKS1 may be involved in DNA DSB repair and/or inflammatory signaling in UC, but a more thorough investigation of both pathways in UC is warranted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29462394     DOI: 10.1093/ibd/izx071

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  5 in total

1.  The NUCKS1-SKP2-p21/p27 axis controls S phase entry.

Authors:  Samuel Hume; Claudia P Grou; Pauline Lascaux; Vincenzo D'Angiolella; Arnaud J Legrand; Kristijan Ramadan; Grigory L Dianov
Journal:  Nat Commun       Date:  2021-11-29       Impact factor: 14.919

2.  IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis.

Authors:  Houmei Wang; Yuanyuan Luo; Rui Ran; Xinya Li; Hongjian Ling; Fang Wen; Tinghe Yu
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

3.  PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.

Authors:  Naoya Ozawa; Takehiko Yokobori; Katsuya Osone; Chika Katayama; Kunihiko Suga; Chika Komine; Yuta Shibasaki; Takuya Shiraishi; Takuhisa Okada; Ryuji Kato; Hiroomi Ogawa; Akihiko Sano; Makoto Sakai; Makoto Sohda; Hitoshi Ojima; Tatsuya Miyazaki; Yoko Motegi; Munenori Ide; Takashi Yao; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

4.  Nucks1 gene polymorphism rs823114 is associated with the positive symptoms and neurocognitive function of patients with schizophrenia in parts of southern China.

Authors:  Xia Wen; Xusan Xu; Xudong Luo; Jinwen Yin; Chunmei Liang; Jinyuan Zhu; Xueyan Nong; Xiudeng Zhu; Fan Ning; Shanshan Gu; Susu Xiong; Jiawu Fu; Dongjian Zhu; Zhun Dai; Dong Lv; Zhixiong Lin; Juda Lin; You Li; Guoda Ma; Yajun Wang
Journal:  Psychiatr Genet       Date:  2021-08-01       Impact factor: 2.458

5.  Targeting survivin sensitizes cervical cancer cells to radiation treatment.

Authors:  Jing Zhou; Xiaojing Guo; Weifen Chen; Liming Wang; Yonglong Jin
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.